Natco Pharma Limited Ondansetron Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Ondansetron Export Records India — #14 Exporter, 90 Shipments, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ondansetron

India Pharmaceutical Trade Intelligence

$121.0M537 Suppliers157 CountriesHS 30049035

ExportsIndia → UNITED STATES58.8%India → AUSTRALIA6.0%

ImportsUNITED STATES → India$21.1K UNITED KINGDOM → India$14.4K

#1 Buyer: GLENMARK PHARMACEUTICALS

Natco Pharma Limited — Ondansetron Exporter #14 | $1.6M Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Ondansetron Exporter Profile

Indian Pharmaceutical Exporter · #14 for Ondansetron · $1.6M export value · DGFT Verified

Natco Pharma Limited is the #14 Indian exporter of Ondansetron with $1.6M in export value and 90 verified shipments. Natco Pharma Limited holds a 1.3% market share in Ondansetron exports across 3 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Ondansetron Export Profile: Buyers & Destinations

Natco Pharma Limited Ondansetron export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Ondansetron?

Country	Value	Shipments	Share
UNITED STATES	$772.6K	33	51.3%
CANADA	$628.0K	53	41.7%
UNITED STATES OF AMERICA	$76.3K	2	5.1%
SINGAPORE	$28.4K	2	1.9%

Who Are the Top Buyers of Ondansetron from Natco Pharma Limited?

Buyer	Country	Value	Orders
LIFE SCIENCE LOGISTICS	UNITED STATES	$728.1K	32
MARCAN PHARMACEUTICALS INC	CANADA	$347.7K	26
NATCO PHARMA CANADA INC	CANADA	$132.7K	12
LIFE SCIENCES LOGISTICS	UNITED STATES	$70.8K	2
MARCAN PHARMACEUTICALS INC,	CANADA	$58.4K	2
TEVA PHARMACEUTICALS USA INC	UNITED STATES	$50.0K	1
NATCO PHARMA (CANADA) INC,	CANADA	$48.0K	3
NATCO PHARMA (CANADA) INC	CANADA	$41.2K	10
NATCO PHARMA ASIA PTE LIMITED	SINGAPORE	$14.3K	1
NATCO PHARMA ASIA PTE LTD,	SINGAPORE	$14.1K	1

Natco Pharma Limited supplies Ondansetron to 10 buyers globally. The largest buyer is LIFE SCIENCE LOGISTICS (UNITED STATES), followed by MARCAN PHARMACEUTICALS INC (CANADA) and NATCO PHARMA CANADA INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ondansetron Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
ONDANSETRON 8MG TABLETS 30'S (OTHER REFE	$50.0K	1
ONDANSETRON 4MG TABLETS 30 S S 153780X30 APPENDIX 4R RODTEP ENTRY NO 10101 OTHER REFERENCE S CI NO 122296	$50.0K	1
ONDANSETRON 4MG TABLETS 30 S 103080X30 3092400 TABLETS CI NO 122306 RODTEP ENTRY NO 10101	$50.0K	1
ONDANSETRON HCL USP 4MG TABLETS 30 SQTY:51348X30SOTHER REFERENCESCI NO:123094;APPENDIX 4R RODTEP ENTRY NO: 10101	$50.0K	1
ONDANSETRON USP 4MG TABLETS 30 S S(154752X30 S) (APPENDIX 4R RODTEP ENTRY NO:10101)(OTHER REFERENCE(S) CI NO: 123121)	$50.0K	1
ONDANSETRON USP 4MG TABLETS 30'S191388X30'SAPPENDIX 4R RODTEP ENTRY NO:10101OTHER REFERENCES CI NO: 123188	$50.0K	1
ONDANSETRON USP 4MG TABLETS 30'S118980X30'S APPENDIX 4R RODTEP ENTRY NO:10101OTHER REFERENCES CI NO: 123190	$50.0K	1
ONDANSETRON USP 4MG TABLETS 30'S(103716X30'S)(APPENDIX 4R,RODTEP ENTRY NO:10101)(OUR REF(S)CI NO:125016)	$49.4K	1
ONDANSETRON 4 MG TABLETS 10'S(12032X10'S) (APPENDIX 4R, RODTEP ENTRY NO:10101)(OTHER REFERENCE(S) CI NO:124022)	$40.7K	3
ONDANSETRON USP 4MG TABLETS 30'S (APPENDIX 4R, RODTEP ENTRY NO:10101)(OTHER REFERENCE CI NO:123294)	$38.9K	1

Natco Pharma Limited exports 71 distinct Ondansetron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ONDANSETRON 8MG TABLETS 30'S (OTHER REFE with 1 shipments worth $50.0K.

How Does Natco Pharma Limited Compare to Nearest Ondansetron Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	INTAS PHARMACEUTICALS LIMITED	$2.5M	511	15	$4.9K
13	DR REDDYS LABORATORIES LIMITED	$1.9M	58	3	$33.4K
14	NATCO PHARMA LIMITED ★	$1.6M	90	3	$18.0K
15	MEDCELL PHARMA	$1.3M	32	3	$40.6K
8	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$750.0K	15	3	$50.0K

Natco Pharma Limited ranks #14 among 537 Indian Ondansetron exporters. Average shipment value of $18.0K compared to the market average of $186.5K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and DR REDDYS LABORATORIES LIMITED.

Which Indian Ports Ship Ondansetron Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,058	12.5%
NHAVA SHEVA SEA (INNSA1)	1,026	12.1%
SAHAR AIR	993	11.7%
HYDERABAD ICD (INSNF6)	509	6.0%
HYDERABAD ICD	448	5.3%
JNPT/ NHAVA SHEVA SEA	343	4.1%
DELHI AIR CARGO ACC (INDEL4)	265	3.1%
AHEMDABAD AIR ACC (INAMD4)	224	2.6%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Ondansetron Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ondansetron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 90 individual customs records matching Natco Pharma Limited exporting Ondansetron, covering 71 formulations to 4 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 157+ countries, 1,636+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ondansetron

Ondansetron

Natco Pharma Limited — Ondansetron Exporter Profile

Natco Pharma Limited — Ondansetron Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Ondansetron?

Who Are the Top Buyers of Ondansetron from Natco Pharma Limited?

What Is India's Total Ondansetron Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Ondansetron Exports?

How Does Natco Pharma Limited Compare to Other Indian Ondansetron Exporters?

What Ondansetron Formulations Does Natco Pharma Limited Export?

Regulatory Requirements: Exporting Ondansetron to Key Markets

United States — FDA

Canada — HC

How Does Natco Pharma Limited Compare to Nearest Ondansetron Exporters?

Which Indian Ports Ship Ondansetron Exports?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Ondansetron Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ondansetron Export Data from Natco Pharma Limited

Ondansetron Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source